• Oncoclínicas submitted a revised out-of-court restructuring plan on October 23, 2026, covering approximately R$ 5.7 billion in unsecured claims, excluding intercompany claims.
• Payment options include new debt, extended repayment schedules and asset transfers, depending on each creditor’s allocation or election.
• The plan also provides for convertible debentures, payment in company shares and discounts under certain payment options.
• Court approval remains subject to formalized creditor support exceeding the statutory minimum and a 30-day creditor objection period following notice publication.
• Operations continue normally, while obligations incurred after the restructuring filing remain outside the plan and continue to be paid.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.